Surgery With Extra Tissue Removal for Pancreatic Head Cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study tests whether removing extra tissue around the pancreas during a standard surgery improves outlook for people with pancreatic head cancer. You may qualify if you have this type of cancer and are planning surgery without prior chemotherapy or radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older.
- You have a type of pancreatic cancer called pancreatic ductal adenocarcinoma, located in the head of the pancreas (confirmed by a biopsy).
- You are scheduled for a surgery (pancreaticoduodenectomy) that removes the tumor along with some nearby tissue.
- Your cancer is considered resectable, meaning it has not spread to distant organs and major blood vessels are not heavily involved.
- You have not received chemotherapy or radiation therapy for this cancer before surgery (so the new surgery's effects can be measured).
- You are in generally good health (able to carry out daily activities) and your major organs (like liver and kidneys) are working well.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a specific surgical method called mesopancreatic excision during Whipple surgery for pancreatic cancer. It may help remove more cancer tissue and improve outcomes for patients with resectable disease.
This trial compares two ways of doing the same surgery to remove a tumor in the pancreas. It looks at whether removing the blood supply to the tumor first makes the surgery safer or more effective than the usual method.
This trial tests a new treatment, PTM-101, placed during a laparoscopy procedure for people with pancreatic cancer that can be removed with surgery. It aims to see if adding this treatment before standard chemotherapy helps improve outcomes.
This study looks at specific body chemistry pathways in pancreatic cancer tissue to better understand what may help treatment work. If you are having pancreatic surgery, the researchers will take extra small tissue samples during the operation to study tumor and normal tissue.
This trial compares two standard surgical techniques for removing pancreatic head tumors: the usual surgery (partial pancreatoduodenectomy) versus a more extended version that removes additional tissue. The goal is to see which approach offers better outcomes for patients, potentially improving survival or reducing recurrence.
This study looks at how the surgeon's cutting edges (margins) and the way the tumor sits in the pancreas affect outcomes for people having surgery for pancreatic cancer. By joining, you'll help researchers learn how to improve surgery and planning for future patients.
Hear when a new Pancreatic Head Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.